Abstract
Breast cancer, one of the most common serious malignancies affecting women, occurs in hereditary and sporadic forms. Hereditary breast cancer accounts for 5–10% of all cases and has some distinctive clinical features compared with sporadic breast cancer. The recently identified genes BRCA1 and BRCA2 appear to account for the majority of hereditary breast cancer in US and European populations. Both of these genes have already been localized and isolate; however, the exact functions of their proteins are not clear yet. The detection of LOH in the 17q21 and 13q12-q13 regions, where the BRCA1 and BRCA2 genes are located, indicates that BRCA1 and BRCA2 act as tumor suppressor genes. The list of identified germline mutations in BRCA1 and BRCA2 is still growing, and mutation carriers have a substantial lifetime risk of both breast and ovarian cancer. However, it is still undetermined whether BRCA1 and BRCA2 play similar important roles in sporadic breast cancer. This paper reviews the current advances in BRCA1/BRCA2 research: the structure of their genes and proteins, their mutation frequencies, their possible roles in both hereditary and sporadic breast cancers, and their functions in transcriptional regulation and DNA repair.
Similar content being viewed by others
References
Claus EB, Risch N, Thompson WD: Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 48: 232–242, 1991
Boring CC, Squires TS, Tong T: Cancer statistics. CA Cancer J Clin 41: 19–36, 1991
Lynch HT, Albano WA, Banes BS, Layton MA, Kimberling WJ, Lynch JF: Genetic predisposition to breast cancer. Cancer 53: 612–622, 1984
Rebbeck TR, Couch FJ, Kant J, Calone K, DeShano M, Peng Y, Chen K, Garber JE, Weber BL: Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2. Am J Hum Genet 59: 547–553, 1996
Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC: Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250: 1684–1689, 1990
Narod DA, Feunteun J, Lynch HT, Watson P, Conway T, Lynch J, Lenoir GM: Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet 338: 82–83, 1991
Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D, Fields P, Marshall G, Narod S, Lenoir GM, Lynch H, Feunteun J, Devilee P, Cornelisse CJ, Menko FH, Daly PA, Ormiston W, McManus R, Pye C, Lewis CM, Cannon-Albright LA, Peto J, Ponder BAJ, Skolnick MH, Easton DF, Goldgar DE, Stratton MR: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12–13. Science 265: 2088–2090, 1994
Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami I, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66–71, 1994
Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Manglon J, Collins N, Gregory S, Gumbs C, Micklem G, Barfoot R, Hamoudi R, Patel S, Rice C, Biggs P, Hashim Y, Smith A, Connor F, Arason A, Gudmundsson J, Ficenec D, Kelsell D, Ford D, Tonin P, Bishop DT, Spurr NK, Ponder BAJ, Eeles R, Peto J, Devilee P, Cornelisse C, Lynch H, Narod S, Lenoir G, Egilsson V, Barkadottir RB, Easton DF, Bentley DR, Futreal PA, Ashworth A, Stratton MR: Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789–792, 1995
Claus EB, Risch NJ, Thompson WD: Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 131: 961–972, 1990
Weber BL: Genetic testing for breast cancer. Sci Am 12–21,1996
Lynch HT, Harris RE, Organ CH, Lynch JF: Management of familial breast cancer 2. Case reports, pedigrees, genetic counseling, and team concept. Arch Surg 113: 1061–1067, 1978
Lynch HT, Harris RE, Guirgis HA, Maloney K, Carmody LL, Lynch JF: Familial association of breast/ovarian carcinoma. Cancer 41: 1543–1549, 1978
Lynch HT, Fain PR, Golgar D, Albano WA, Mailliard JA, McKenna P: Familial breast cancer and its recognition in an oncology clinic. Cancer 47: 2730–2739, 1981
Marcus JN, Watson P, Page DL, Narod SA, Lenoir GM, Tonin P, Linder-Stephenson L, Salerno G, Conway TA, Lynch HT: Hereditary breast cancer. Cancer 77: 697–709, 1996
Eisinger F, Stoppa-Lyonnet D, Longy M, Kerangueven F, Noguchi T, Bailly C, Vincent-Salomon A, Jacquemier J, Birnbaum D, Sobol H: Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res 56: 471–474, 1996
Sobol H, Stoppa-Lyonnet D, Bressac-de-Paillerets B, Peyrat JP, Kerangueven F, Janin N, Noguchi T, Eisinger F, Guinebretiere JM, Jacquemier J, Birnbaum D: Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancers. Cancer Res 56: 3216–3219, 1996
Lovering R, Hanson IM, Borden KLB, Martin S, O'Reilly NJ, Evan GI, Rahman D, Pappin DJC, Trowsdale J, Freemont PS: Identification and preliminary characterization of a protein motif related to the zinc finger. Proc Natl Acad Sci USA 90: 2112–2116, 1993
Bienstock RJ, Darden T, Wiseman R, Pedersen L, Barrett JC: Molecular modeling of the amino-terminal zinc ring domain of BRCA1. Cancer Res 56: 2539–2545, 1996
Chapman MS, Verma IM: Transcriptional activation by BRCA1. Nature 382: 678–967, 1996
Ouchi T, Monteiro ANA, August A, Aaronson SA, Hanafusa H: BRCA1 regulates p53-dependent gene expression. Proc Natl Acad Sci USA 95: 2302–2306, 1998
Scully R, Anderson SF, Chao DM, Wei W,Ye L, Young RA, Livingston DM, Parvin JD: BRCA1 is a component of the RNA polymerase II holoenzyme. Proc Natl Acad Sci USA 94: 5605–5610, 1997
Koonin EV, Altschul SF, Bork P: BRCA1 protein products... Functional motifs... Nature Genet 13: 266–267, 1996
Callebaut I, Mornon J-P: From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair. FEBS Lett 400: 25–30, 1997
Wu LC, Wang ZW, Tsan JT, Spillman MA, Phung A, Xu XL, Yang MCW, Hwang LY, Bowcock AM, Baer R: Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nature Genet 14: 430–440, 1996
Jin Y, Xu XL, Yang M-CW, Wei F, Ayi T-C, Bowcock AM, Baer R: Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains. Proc Natl Acad Sci USA 94: 12075–12080, 1997
Jensen DE, Proctor M, Marquis ST, Gardner HP, Ha SI, Chodosh LA, Ishov AM, Tommerup N, Vissing H, Sekido Y, Minna J, Borodovsky A, Schultz DC, Wilkinson KD, Maul GG, Barlev N, Berger SL, Prendergast GC, Rauscher FJ III: BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene 16: 1097–1112, 1998
Chen Y, Farmer AA, Chen CF, Jones DC, Chen PL, Lee WH: BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res 56: 3168–3172, 1996
Chen Y, Chen CF, Riley DJ, Allred DC, Chen PL, von Hoff DD, Osborne CK, Lee WH: Aberrant subcellular localization of BRCA1 in breast cancer. Science 270: 789–791, 1995
Scully R, Ganesan S, Brown M, Caprio JAD, Cannistra SA, Feunteun J: Location of BRCA1 in human breast and ovarian cancer cells. Science 272: 123–125, 1996
Chen C-F, Li S, Chen Y, Chen PL, Sharp ZD, Lee WH: The nuclear localization sequences of the BRCA1 protein interact with the importin-a subunit of the nuclear transport signal receptor. J Biol Chem 271: 32863–32868, 1996
Gudas JM, Nguyen H, Li T, Cowan KH: Hormonedependent regulation of BRCA1 in human breast cancer cells. Cancer Res 55: 4561–4565, 1995
Jensen R, Thompson ME, Jetton TL, Szabo CI, Meer RVD, Helou B, Tronick SR, Page DL, King MC, Holt JT: BRCA1 is secreted and exhibits properties of a granin. Nat Genet 12: 303–308, 1996
Wilson CA, Payton MN, Pekar SK, Zhang K, Pacifici RE, Gudas JL, Thukral S, Calzone FJ, Reese DM, Slamon DI: BRCA1 protein products: antibody specificity. Nat Genet 13: 264–265, 1996
Thomas JE, Smith M, Rubinfeld B, Gutowski M, Beckmann RP, Polakis P: Subcellular localization and analysis of apparent 180-kDa and 220-kDa proteins of the breast cancer susceptibility gene, BRCA1. J Biol Chem 271: 28630–28635, 1996
Smith SA, Easton DG, Evans DGR, Ponder BAJ: Allele losses in the region 17q12–21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat Genet 2: 128–131, 1992
Marcus JN, Watson P, Page DL, Lynch HT: Pathology and heredity of breast cancer in younger women. J Natl Cancer Inst Monograph 16: 23–34, 1994
Thompson ME, Jensen RA, Obermiller PS, Page DL, Holt JT: Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast progression. Nat Genet 9: 444–450, 1995
Rao VN, Shao N, Ahmad M, Shyam E, Reddy P: Antisense RNA to the putative tumor suppressor gene BRCA1 transforms mouse fibroblasts. Oncogene 12: 523–528, 1996
Kainu T, Kononen J, Johansson O, Olsson H, Borg A, Isola J: Detection of germlineBRCA1mutations in breast cancer patients by quantitative messenger RNA in situ hybridization. Cancer Res 56: 2912–2915, 1996
Shao N, Chai YL, Shyam E, Reddy P, Rao VN: Induction of apoptosis by the tumor suppressor protein BRCA1. Oncogene 13: 1–7, 1996
Vaughn JP, Davis PL, Jarboe MD, Huper G, Evans AC, Wiseman RW, Berchuck A, Iglehart JD, Futreal PA, Marks JR: BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth Differ 7: 711–715, 1996
Gudas JM, Li T, Nguyen H, Jensen D, Rauscher FJ, Cowan KH: Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Cell Growth Differ 7: 717–723, 1996
Liu C-Y, Flesken-Nikitin A, Li S, Zeng Y, Lee W-H: Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Development 10: 1835–1843, 1996
Easton DF, Bishop DT, Ford D, Crockford GP, Breast Cancer Linkage Consortium: Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 52: 678–701, 1993
Stratton MR, Ford D, Neuhasen S, Seal S, Wooster R, Friedman LS, King MC, Egilsson V, Devilee P, McManus R, Daly PA, Smyth E, Ponder BAJ, Peto J, Cannon-Albright L, Easton DF, Goldgar DE: Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nat Genet 7: 103–107, 1994
Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y, Eddington K, McClure M, Frye C, Weaver-Feldhaus J, Ding W, Gholami Z, Soderkvist P, Terry L, Jhanwar S, Berchuck A, Iglehart JD, Marks J, Ballinger DG, Barrett JC, Skolnick MH, Kamb A, Wiseman R: BRCA1 mutation in primary breast and ovarian carcinomas. Science 266: 120–122, 1994
Collins FS: BRCA1 – Lots of mutations, lots of dilemmas. New England J Med 334: 186–188, 1996
Ford D, Easton DF: The genetics of breast and ovarian cancer. Br J Cancer 72: 805–812, 1995
Feunteun J, Lenoir GM: BRCA1, a gene involved in inherited predisposition to breast and ovarian cancer. Biochim Biophys Acta 1242: 177–180, 1996
Inoue R, Fukutomi T, Ushijima T, Matsumoto Y, Sugimura T, Nagao M: Germline mutation of BRCA1 in Japanese breast cancer families. Cancer Res 55: 3521–3524, 1995
Egan KM, Newcomb PA, Longnecker MP, Trentham-Dietz A, Baron JA, Trichopoulos D, Stampfer MJ, Willett WC: Jewish religion and risk of breast cancer. Lancet 347: 1645–1646, 1996
Struewing JR, Abeliovitch D, Peretz T, Avishai N, Kaback MM, Collins FS, Brody LC: The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 11: 198–200, 1995
Andersen TI, Borresen A, Moller P: A common BRCA1 mutation in Norwegian breast and ovarian cancer families? Am J Hum Genet 59: 486–487, 1996
Caligo MA, Ghimenti C, Cipollini G, Ricci S, Brunetti I, Marchetti V, Olsen R, Neuhausen S, Shattuck-Eidens D, Conte P, Skolnick MH, Bevilacqua G: BRCA1 germline mutational spectrum in Italian families fromTuscany: a high frequency of novel mutations. Oncogene 13: 1483–1488, 1996
Easton DF, Narod SA, Ford D, Steel M: The genetic epidemiology of BRCA1. Lancet 344: 761, 1994
Bishop DT: BRCA1, BRCA2, BRCA3... A myriad of breast cancer genes. Eur J Cancer 30A: 1738–1739, 1994
Ford D, Easton DF, Peto J: Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 57: 1457–1462, 1995
Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE: Risks of cancer in BRCA1-mutation carriers. Lancet 343: 692–95, 1994
Weber BL: Familial breast cancer. Recent Results in Cancer Res 140: 5–16, 1996
Couch FJ, Farid LM, DeShano ML, Tavtigian SV, Calzone K, Campeau L, Peng Y, Bogden B, Chen Q, Neuhausen S, Shattuck-Eidens D, Godwin AK, Daly M, Radford DM, Sedlacek S, Rommens J, Simard J, Garber J, Merajver S, Weber BL: BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet 13: 123–125, 1996
Roa BB, Boyd AA, Volcik K, Richards CS: Ashkenazi Jewish population frequencies for common mutations inBRCA1 and BRCA2. Nat Genet 14: 185–187, 1996
Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Merajver S, Thorlacius S, Offit K, Stoppa-Lyonnet D, Belanger C, Bell R, Berry S, Bogden R, Chen Q, Davis T, Dumont M, Frye C, Hattier T, Jammulapati S, Janecki T, Jiang P, Kehrer R, Leblanc JF, Mitchell JT, McArthur-Morrison J, Nguyen K, Peng Y, Samson C, Schroeder M, Snyder SC, Steele L, Stringfellow M, Stroup C, Swedlund B, Swensen J, Teng D, Thomas A, Tran T, Tran T, Tranchant M, Weaver-Feldhans J, Wong AKC, Shizuya H, Eyfjord JE, Cannon-Albright L, Labrie F, Skolnick MH, Weber B, Kamb A, Goldgar DE: The complete BRCA2 gene and mutations in chromosomes 13q-linked kindreds. Nat Genet 12: 333–337, 1996
Milner J, Ponder B, Hughes-Davies L, Seltmann M, Kouzarides T: Transcriptional activation functions in BRCA2. Nature 386: 772–773, 1997
Wong AKC, Pero R, Ormonde PA, Tavigian SV, Bartel PL: Rad51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene BRCA2. J Biol Chem 272: 31941–31944, 1997
Vaughn JP, Cirisano FD, Huper G, Berchuck A, Futreal PA, Marks JR, Iglehart JD: Cell cycle control of BRCA2. Cancer Res 56: 4590–4594, 1996
Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T, Livingston DM: Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88: 265–275, 1997
Scully R, Chen J, Ochs RL, Keegan K, Hoekstra M, Feunteun J, Livingston DM: Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90: 425–435, 1997
Sharan SK, Morimatsu M, Albrecht U, Lim DS, Regel E, Dinh C, Sands A, Eichele G, Hasty P, Bradley A: Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386: 804–810, 1997
Cleton-Jansen AM, Collins N, Lakhani SR, Weissenbach J, Devilee P, Cornelisse CJ, Stratton MR: Loss of heterozygosity in sporadic breast tumors at the BRCA2 locus on chromosome 13q12-q13. Br J Cancer 72: 1241–1244, 1995
Teng DHF, Bogden R, Mitchell J, Baumgard M, Bell R, Berry S, Davis T, Ha PC, Kehrer R, Jammulapati S, Chen Q, Offit K, Skolnick MH, Tavtigian SV, Jhanwar S, Swedlund B, Wong AKC, Kamb A: Low incidence of BRCA2 mutations in breast carcinoma and other cancers. Nat Genet 13: 241–247, 1996
Miki Y, Katagire T, Kasumi F, Yoshimoto T, Nakamura Y: Mutation analysis in the BRCA2 gene in primary breast cancer. Nat Genet 13: 245–247, 1996
Lancaster JM, Wooster R, Mangion J, Phelan CM, Cochran C, Gumbs C, Seal S, Barfoot R, Collins N, Bignell G, Patel S, Hamoudi R, Larsson C, Wiseman RW, Berchuck A, Iglehart JD, Marks JR, Ashworth A, Stratton MR, Futreal PA: BRCA2 mutations in primary breast and ovarian cancers. Nat Genet 13: 238–240, 1996
Weber BHF, Brohm M, Stec I, Backe J, Caffier H: Asomatic truncating mutation in BRCA2 in a sporadic breast tumor. Am J Hum Genet 59: 962–964, 1996
Vogelstein B, Kinzler KW: Has the breast cancer gene been found? Cell 79: 1–3, 1994
Holt JT, Thompson ME, Szabo C, Robinson-Benion C, Arteaga CL, King MC, Jensen RA: Growth retardation and tumour inhibition by BRCA1. Nat Genet 12: 298–302, 1996
Merajver SD, Pham TM, Caduff RF, Chen M, Poy EL, Cooney KA, Weber BL, Collins FS, Johnston C, Frank TS: Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nat Genet 9: 439–443, 1995
Thakur S, Zhang HB, Peng YI, Li H, Carroll B, Ward T, Yao J, Farid LM, Couch FJ, Wilson RB, Weber BL: Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol Cell Biol 17: 444–452, 1997
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yang, X., Lippman, M.E. BRCA1 and BRCA2 in breast cancer. Breast Cancer Res Treat 54, 1–10 (1999). https://doi.org/10.1023/A:1006189906896
Issue Date:
DOI: https://doi.org/10.1023/A:1006189906896